| UniProt ID | AGAP3_HUMAN | |
|---|---|---|
| UniProt AC | Q96P47 | |
| Protein Name | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 3 | |
| Gene Name | AGAP3 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 875 | |
| Subcellular Localization | Cytoplasm . In cells upon oxidative stress or in brains of Machado-Joseph disease patients, translocates to PML nuclear bodies. | |
| Protein Description | GTPase-activating protein for the ADP ribosylation factor family (Potential). GTPase which may be involved in the degradation of expanded polyglutamine proteins through the ubiquitin-proteasome pathway.. | |
| Protein Sequence | MNFQAGGGQSPQQQQQLAGGPPQQFALSNSAAIRAEIQRFESVHPNIYAIYDLIERIEDLALQNQIREHVISIEDSFVNSQEWTLSRSVPELKVGIVGNLSSGKSALVHRYLTGTYVQEESPEGGRFKKEIVVDGQSYLLLIRDEGGPPELQFAAWVDAVVFVFSLEDEISFQTVYNYFLRLCSFRNASEVPMVLVGTQDAISAANPRVIDDSRARKLSTDLKRCTYYETCATYGLNVERVFQDVAQKVVALRKKQQLAIGPCKSLPNSPSHSAVSAASIPAVHINQATNGGGSAFSDYSSSVPSTPSISQRELRIETIAASSTPTPIRKQSKRRSNIFTSRKGADLDREKKAAECKVDSIGSGRAIPIKQGILLKRSGKSLNKEWKKKYVTLCDNGLLTYHPSLHDYMQNIHGKEIDLLRTTVKVPGKRLPRATPATAPGTSPRANGLSVERSNTQLGGGTGAPHSASSASLHSERPLSSSAWAGPRPEGLHQRSCSVSSADQWSEATTSLPPGMQHPASGPAEVLSSSPKLDPPPSPHSNRKKHRRKKSTGTPRPDGPSSATEEAEESFEFVVVSLTGQTWHFEASTAEERELWVQSVQAQILASLQGCRSAKDKTRLGNQNAALAVQAVRTVRGNSFCIDCDAPNPDWASLNLGALMCIECSGIHRHLGAHLSRVRSLDLDDWPPELLAVMTAMGNALANSVWEGALGGYSKPGPDACREEKERWIRAKYEQKLFLAPLPSSDVPLGQQLLRAVVEDDLRLLVMLLAHGSKEEVNETYGDGDGRTALHLSSAMANVVFTQLLIWYGVDVRSRDARGLTPLAYARRAGSQECADILIQHGCPGEGCGLAPTPNREPANGTNPSAELHRSPSLL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 42 | Phosphorylation | AEIQRFESVHPNIYA HHHHHHHCCCCHHHH | 24.02 | 24719451 | |
| 51 | Phosphorylation | HPNIYAIYDLIERIE CCHHHHHHHHHHHHH | 9.13 | 24719451 | |
| 78 (in isoform 4) | Phosphorylation | - | 8.57 | 24719451 | |
| 87 (in isoform 4) | Phosphorylation | - | 44.80 | 24719451 | |
| 111 | Phosphorylation | KSALVHRYLTGTYVQ CCHHHHHHHHCCEEE | 8.17 | 20068231 | |
| 113 | Phosphorylation | ALVHRYLTGTYVQEE HHHHHHHHCCEEEEE | 20.67 | 20068231 | |
| 115 | Phosphorylation | VHRYLTGTYVQEESP HHHHHHCCEEEEECC | 18.45 | 20068231 | |
| 116 | Phosphorylation | HRYLTGTYVQEESPE HHHHHCCEEEEECCC | 11.07 | 20068231 | |
| 121 | Phosphorylation | GTYVQEESPEGGRFK CCEEEEECCCCCCCE | 27.74 | 21815630 | |
| 147 | Phosphorylation | LLIRDEGGPPELQFA EEEECCCCCHHHHHH | 32.32 | 20068231 | |
| 157 (in isoform 4) | Phosphorylation | - | 2.65 | 24719451 | |
| 157 | Phosphorylation | ELQFAAWVDAVVFVF HHHHHHHCCEEEEEE | 2.65 | 20068231 | |
| 184 | Phosphorylation | NYFLRLCSFRNASEV HHHHHHHCCCCCCCC | 31.65 | 24719451 | |
| 219 | Phosphorylation | DSRARKLSTDLKRCT HHHHHHHCCHHHHCC | 23.94 | - | |
| 220 (in isoform 4) | Phosphorylation | - | 56.65 | 24719451 | |
| 318 | Phosphorylation | QRELRIETIAASSTP HHCEEEEEHHHCCCC | 17.34 | 23403867 | |
| 322 | Phosphorylation | RIETIAASSTPTPIR EEEEHHHCCCCCCCC | 26.23 | 29255136 | |
| 323 | Phosphorylation | IETIAASSTPTPIRK EEEHHHCCCCCCCCC | 33.41 | 29255136 | |
| 324 | Phosphorylation | ETIAASSTPTPIRKQ EEHHHCCCCCCCCCC | 28.78 | 29255136 | |
| 326 (in isoform 3) | Phosphorylation | - | 31.28 | 25159151 | |
| 326 | Phosphorylation | IAASSTPTPIRKQSK HHHCCCCCCCCCCHH | 31.28 | 29255136 | |
| 332 | Phosphorylation | PTPIRKQSKRRSNIF CCCCCCCHHHHCCCC | 31.03 | 24117733 | |
| 336 | Phosphorylation | RKQSKRRSNIFTSRK CCCHHHHCCCCCCCC | 38.01 | 21712546 | |
| 343 | Methylation | SNIFTSRKGADLDRE CCCCCCCCCCCCCHH | 59.21 | - | |
| 359 | Phosphorylation | KAAECKVDSIGSGRA HHHCCCCCCCCCCCC | 21.74 | 19413330 | |
| 359 (in isoform 4) | Phosphorylation | - | 21.74 | 24719451 | |
| 360 | Phosphorylation | AAECKVDSIGSGRAI HHCCCCCCCCCCCCE | 31.66 | 19413330 | |
| 362 (in isoform 6) | Phosphorylation | - | 28.18 | 25159151 | |
| 362 (in isoform 4) | Phosphorylation | - | 28.18 | 24719451 | |
| 362 | Phosphorylation | ECKVDSIGSGRAIPI CCCCCCCCCCCCEEE | 28.18 | 20068231 | |
| 372 (in isoform 4) | Phosphorylation | - | 13.91 | 24719451 | |
| 372 | Phosphorylation | RAIPIKQGILLKRSG CCEEECCCEEEEECC | 13.91 | 18669648 | |
| 390 | Phosphorylation | NKEWKKKYVTLCDNG CHHHHHHEEEECCCC | 13.93 | - | |
| 435 | Phosphorylation | GKRLPRATPATAPGT CCCCCCCCCCCCCCC | 18.09 | 23403867 | |
| 438 | Phosphorylation | LPRATPATAPGTSPR CCCCCCCCCCCCCCC | 34.29 | 30266825 | |
| 442 | Phosphorylation | TPATAPGTSPRANGL CCCCCCCCCCCCCCC | 34.20 | 23459991 | |
| 443 | Phosphorylation | PATAPGTSPRANGLS CCCCCCCCCCCCCCE | 20.50 | 30266825 | |
| 450 | Phosphorylation | SPRANGLSVERSNTQ CCCCCCCEEECCCCC | 24.27 | 29255136 | |
| 462 | Phosphorylation | NTQLGGGTGAPHSAS CCCCCCCCCCCCCCC | 33.18 | 27251275 | |
| 467 | Phosphorylation | GGTGAPHSASSASLH CCCCCCCCCCCCCCC | 28.87 | 27251275 | |
| 469 | Phosphorylation | TGAPHSASSASLHSE CCCCCCCCCCCCCCC | 29.47 | 27251275 | |
| 470 | Phosphorylation | GAPHSASSASLHSER CCCCCCCCCCCCCCC | 22.92 | 27251275 | |
| 472 | Phosphorylation | PHSASSASLHSERPL CCCCCCCCCCCCCCC | 28.67 | 27251275 | |
| 478 | Phosphorylation | ASLHSERPLSSSAWA CCCCCCCCCCCCCCC | 32.32 | 19664995 | |
| 478 (in isoform 4) | Phosphorylation | - | 32.32 | 24719451 | |
| 479 | Phosphorylation | SLHSERPLSSSAWAG CCCCCCCCCCCCCCC | 10.98 | 16964243 | |
| 479 (in isoform 4) | Phosphorylation | - | 10.98 | 27251275 | |
| 480 | Phosphorylation | LHSERPLSSSAWAGP CCCCCCCCCCCCCCC | 25.57 | 26552605 | |
| 481 | Phosphorylation | HSERPLSSSAWAGPR CCCCCCCCCCCCCCC | 31.58 | 26552605 | |
| 482 | Phosphorylation | SERPLSSSAWAGPRP CCCCCCCCCCCCCCC | 25.18 | 26552605 | |
| 486 (in isoform 4) | Phosphorylation | - | 14.19 | 27251275 | |
| 496 | Phosphorylation | PEGLHQRSCSVSSAD CCCCCCCCCCCCCHH | 12.27 | 27080861 | |
| 498 | Phosphorylation | GLHQRSCSVSSADQW CCCCCCCCCCCHHHH | 26.70 | 27080861 | |
| 498 (in isoform 4) | Phosphorylation | - | 26.70 | 27251275 | |
| 500 | Phosphorylation | HQRSCSVSSADQWSE CCCCCCCCCHHHHHH | 11.96 | 27080861 | |
| 501 | Phosphorylation | QRSCSVSSADQWSEA CCCCCCCCHHHHHHC | 33.44 | 27080861 | |
| 534 (in isoform 4) | Phosphorylation | - | 60.84 | 27251275 | |
| 537 (in isoform 4) | Phosphorylation | - | 66.92 | 27251275 | |
| 538 | Phosphorylation | PKLDPPPSPHSNRKK CCCCCCCCCCCCCHH | 40.81 | 30266825 | |
| 541 | Phosphorylation | DPPPSPHSNRKKHRR CCCCCCCCCCHHHCC | 41.54 | 23927012 | |
| 551 | Phosphorylation | KKHRRKKSTGTPRPD HHHCCCCCCCCCCCC | 34.79 | 24275569 | |
| 574 (in isoform 4) | Phosphorylation | - | 3.06 | 24719451 | |
| 676 | Phosphorylation | RHLGAHLSRVRSLDL HHHHHHHHCCCCCCC | 20.89 | - | |
| 732 | Acetylation | KERWIRAKYEQKLFL HHHHHHHHHHHHEEE | 39.20 | 7234275 | |
| 825 | Phosphorylation | RGLTPLAYARRAGSQ CCCCHHHHHHHCCCH | 14.34 | 18083107 | |
| 862 | Phosphorylation | NREPANGTNPSAELH CCCCCCCCCCCHHHH | 43.70 | 27251275 | |
| 865 | Phosphorylation | PANGTNPSAELHRSP CCCCCCCCHHHHCCC | 36.12 | 27251275 | |
| 871 | Phosphorylation | PSAELHRSPSLL--- CCHHHHCCCCCC--- | 14.21 | 26074081 | |
| 873 | Phosphorylation | AELHRSPSLL----- HHHHCCCCCC----- | 43.48 | 26074081 | |
| 901 (in isoform 4) | Phosphorylation | - | 27251275 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AGAP3_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGAP3_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGAP3_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of AGAP3_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-324; THR-326 ANDSER-336, AND MASS SPECTROMETRY. | |
| "A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-443, AND MASSSPECTROMETRY. | |